Efficacy of repetitive transcranial magnetic stimulation treatment with MPTP Parkinson's disease mice

Efficacy of repetitive transcranial magnetic stimulation treatment with MPTP Parkinson's disease mice

Objective To observe the efficacy of the treatment of repetitive transcranial magnetic stimulation (rTMS) on the 1 ⁃ methyl ⁃ 4 ⁃ phenyl ⁃ 1, 2, 3, 6 ⁃ tetrahydropyridine (MPTP) mouse model of Parkinson's disease (PD). Methods Fifty⁃six C57BL/6J male mice were divided into 4 groups: PD model gr...

Full description

Bibliographic Details
Main Authors:	Mingwei WANG, Quandong WANG, Qiaoyun DONG, Jing QIANG, Qinying MA
Format:	Article
Language:	English
Published:	Tianjin Huanhu Hospital 2011-02-01
Series:	Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:	Parkinson disease 1⁃Methyl⁃4⁃phenyl⁃1, 2, 3, 6⁃tetrahydropyridine Transcranial magnetic stimulation Tyrosine 3⁃monooxygenase Dopamine Immunohistochemistry Disease models, animal
Online Access:	http://www.cjcnn.org/index.php/cjcnn/article/view/316

Similar Items

Relationship Between the Anxious Symptoms and the Neurotransmitter in Parkinson's Mice with Different Dosages of MPTP
by: Yu Xia, et al.
Published: (2018-11-01)

Date preliminare privind unele manifestări ale durerii într-un model de șobolan MPTP-indus a bolii Parkinson
by: Daniela Carmen Ababei, et al.
Published: (2015-06-01)

Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism
by: Elena A. Kozina, et al.
Published: (2017-02-01)

Neuroprotective and Anti-Inflammatory Effects of Evernic Acid in an MPTP-Induced Parkinson’s Disease Model
by: Seulah Lee, et al.
Published: (2021-02-01)

Análise histomorfométrica do músculo sóleo de ratos submetidos ao modelo animal de parkinsonismo induzido pelo MPTP
by: Ana Paula Cunha Loureiro, et al.

Multi-Target Protective Effects of Gintonin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Mediated Model of Parkinson’s Disease via Lysophosphatidic Acid Receptors
by: Jong Hee Choi, et al.
Published: (2018-05-01)

Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration
by: Dong-Young Choi, et al.
Published: (2013-01-01)

Bone marrow-derived microglia contribute to the neuroinflammatory response and express iNOS in the MPTP mouse model of Parkinson's disease
by: Erzsebet Kokovay, et al.
Published: (2005-08-01)

Neuroprotective effect of ketamine/xylazine on two rat models of Parkinson's disease
by: M.M. Ferro, et al.
Published: (2007-01-01)

Neuroprotective Effects of a Traditional Multi-Herbal Medicine Kyung-Ok-Ko in an Animal Model of Parkinson's Disease: Inhibition of MAPKs and NF-κB Pathways and Activation of Keap1-Nrf2 Pathway
by: Jong Hee Choi, et al.
Published: (2018-12-01)

Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson’s Disease Mouse Model
by: Hyunjun Park, et al.
Published: (2020-10-01)

Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons
by: Haruhiko Kishima, et al.
Published: (2004-07-01)

Icaritin Provides Neuroprotection in Parkinson’s Disease by Attenuating Neuroinflammation, Oxidative Stress, and Energy Deficiency
by: Hao Wu, et al.
Published: (2021-03-01)

Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC
by: Bruce Do Van, et al.
Published: (2016-10-01)

In vivo and in vitro studies on the role of metallothionein in MPTP/MPP⁺-induced neurotoxicity.
Published: (2000)

Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson’s disease
by: Michael D. Boska, et al.
Published: (2007-06-01)

LY354740 Reduces Extracellular Glutamate Concentration, Inhibits Phosphorylation of Fyn/NMDARs, and Expression of PLK2/pS129 α-Synuclein in Mice Treated With Acute or Sub-Acute MPTP
by: Yang Tan, et al.
Published: (2020-02-01)

Mitochondrial E3 Ubiquitin Ligase Parkin: Relationships with Other Causal Proteins in Familial Parkinson’s Disease and Its Substrate-Involved Mouse Experimental Models
by: Satoru Torii, et al.
Published: (2020-02-01)

Tp53 gene mediates distinct dopaminergic neuronal damage in different dopaminergic neurotoxicant models
by: Tao Lu, et al.
Published: (2017-01-01)

Mucuna pruriens Protects against MPTP Intoxicated Neuroinflammation in Parkinson’s Disease through NF-κB/pAKT Signaling Pathways
by: Sachchida N. Rai, et al.
Published: (2017-12-01)

Animal Models for Parkinson’s Disease Research: Trends in the 2000s
by: Kyohei Kin, et al.
Published: (2019-10-01)

Comparative analysis of dose-dependent neurotoxic response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 N mice derived from three different sources
by: Dong-Joo Hwang, et al.
Published: (2019-07-01)

A Comprehensive Phenotype of Non-motor Impairments and Distribution of Alpha-Synuclein Deposition in Parkinsonism-Induced Mice by a Combination Injection of MPTP and Probenecid
by: Na-Ra Han, et al.
Published: (2021-01-01)

An in vitro study on astrocytic glutathione metabolism after MPTP treatment.
Published: (1995)

Curcumin and an antioxidant formulation protect C57BL/6J mice from MPTP-induced Parkinson’s disease like changes: potential neuroprotection for neurodegeneration
by: Muthian G, et al.
Published: (2018-11-01)

An in vitro study on astrocytic nitric oxide production after MPTP treatment.
Published: (1997)

The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mice myocardial morphology
by: Tais H.C. Sasahara, et al.

Mitigation Effects of a Novel Herbal Medicine, Hepad, on Neuroinflammation, Neuroapoptosis, and Neuro-Oxidation
by: Da Hye Song, et al.
Published: (2018-11-01)

Neuroprotective potential of quercetin in combination with piperine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
by: Shamsher Singh, et al.
Published: (2017-01-01)

Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice
by: Wang Qingshan, et al.
Published: (2012-06-01)

Metabolic engineering of Escherichia coli BL21 (DE3) for de novo production of l-DOPA from d-glucose
by: Eric Fordjour, et al.
Published: (2019-04-01)

Korean Red Ginseng protects dopaminergic neurons by suppressing the cleavage of p35 to p25 in a Parkinson's disease mouse model
by: Ye Lee Jun, et al.
Published: (2015-04-01)

A study of the neurotoxicity of MPTP and analogs in human neuroblastoma SH-SY5Y cells
by: Song, Xiaoou
Published: (2014)

Decoupling neuronal oscillations during subthalamic nucleus stimulation in the parkinsonian primate
by: A. Moran, et al.
Published: (2012-01-01)

Biomechanical Assessment of Normal and Parkinsonian Gait in the Non-human Primate During Treadmill Locomotion
by: Thota, Anil K.
Published: (2012)

Therapeutic effect of low-requency repetitive transcranial magnetic stimulation on Parkinson's disease associated with pain
by: Yang ZHU, et al.
Published: (2019-06-01)

Clinical effects of repetitive transcranial magnetic stimulation therapy on Parkinson's disease: a Meta-analysis
by: Xue-fei ZHAO, et al.
Published: (2015-04-01)

Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish
by: Ville Sallinen, et al.
Published: (2010-10-01)

The application of low frequency repetitive transcranial magnetic stimulation in rehabilitation of Parkinson's disease patients
by: Zhuo-hua WU, et al.
Published: (2013-07-01)

Beneficial effects of L-arginine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuronal degeneration in substantia nigra of Balb/c mice
by: Javad Hami, et al.
Published: (2016-01-01)

Cannot write session to /tmp/vufind_sessions/sess_r20dpa64aro2tvrrkhlpne6le4